App Store

Google Play

DK - Details page - Device banner - 894x1036

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

Lyt når som helst, hvor som helst 

Bloomberg and iHeartPodcasts


The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.


Big Take

The Trump Administration wants to “make America healthy again” and one of its top priorities is removing artificial dyes from food. The company behind Welch’s Fruit Snacks has spent the past ten years doing just that.
 
On today’s Big Take podcast, Bloomberg’s Will Kubzansky takes us inside the Welch’s factory and explores the challenges America’s other food and drink companies could face as they try to meet the MAHA moment and make a similar change under a much faster timeline.
 
Read more: Making Fruit Snacks Without Synthetic Dye

See omnystudio.com/listener for privacy information.

Welch’s Fruit Snacks Get a MAHA-Friendly Makeover

From Starbucks and Intel to Petco and Astronomer: top CEOs are getting replaced at record rates. And the costs of these ousters can spiral quickly, dinging a company’s stock price and costing us all in surprising ways in the process. 
 
On today’s Big Take podcast, Bloomberg’s management and work reporter Matthew Boyle joins host Sarah Holder to dig into the often murky, always steep cost of a CEO ouster.
 
Read more: The True Cost of Firing a CEO

See omnystudio.com/listener for privacy information.

What Does It Cost to Replace a CEO?

After meeting with President Trump separately, Presidents Putin and Zelenskiy could be headed toward a pivotal face-to-face meeting to begin peace talks. But what each side is willing to give up to end the Russia-Ukraine war remains to be seen.
 
On today’s Big Take podcast, David Gura sits down with Bloomberg’s White House correspondent Justin Sink and Europe government editor Piotr Skolimowski to discuss Russia and Ukraine’s red lines and the role the US and Europe could play in guaranteeing a ceasefire.

See omnystudio.com/listener for privacy information.

What Could Happen Next in the Russia-Ukraine Peace Process

At this point in the war between Israel and Hamas, it’s difficult to get more than anecdotal evidence out of Gaza. Almost every organization that once provided aid and monitored civilian welfare is no longer allowed in — or has ceased operations. Very few journalists are left there. 

But reports of a civilian population facing a hunger crisis are widespread.
 
To understand the reality on the ground, host David Gura talked to Bloomberg’s Israel bureau chief Ethan Bronner, UN reporter Magdalena Del Valle and Gaza reporter Fares Alghoul to understand how a hunger crisis unfolded there despite months of warnings.
 
Read more: 
 
How Gaza Descended Into a Hunger Crisis, Explained 
 
Israel Intends to Fully Take Over Gaza Despite Global Isolation

See omnystudio.com/listener for privacy information.

How The Hunger Crisis in Gaza Unfolded Despite Months of Warnings

When a shortage of brand-name weight-loss drugs like Ozempic and Wegovy cleared the way for companies like Hims to fill the gap with cheaper, compounded versions, customers came flocking. But in February, the US Food and Drug Administration announced the shortage was over, leaving the company's strategy in flux and some investors worried.
 
On today’s Big Take podcast, host David Gura and Bloomberg healthcare reporter Madison Muller track how Hims became the king of copycat weight-loss drugs and what’s next for the company as it fights to hold onto the crown. 
 
Read more: How Hims Became the King of Knockoff Weight-Loss Drugs
 
Cheap Ozempic Knockoffs Are Suddenly Everywhere. Are They Safe?
 
The Weight-Loss Drug Boom’s Prescription Problem
 
Listen and follow The Big Take on Apple Podcasts, Spotify or wherever you get your podcasts.

See omnystudio.com/listener for privacy information.

Hims Wants to Keep Mailing You Copycat GLP-1s. It’s Getting Trickier.

In an unusual deal, Nvidia and Advanced Micro Devices have agreed to pay the US government 15% of their revenue from AI chips they sell to China. The US has blocked the sale of other, more powerful chips to China on the basis of national security, but the exception underscores the Trump administration’s openness to make exceptions… if the price is right.
 
On today’s Big Take podcast, Bloomberg economic statecraft reporter Joe Deaux joins host Sarah Holder to explain the unprecedented nature of the deal, concerns about its legality and how it fits into Trump’s approach to trade with global competitors.

See omnystudio.com/listener for privacy information.

Why Trump Is Letting Nvidia Sell (Some) AI Chips to China

President Donald Trump is heading to Alaska to host a face-to-face meeting with his Russian counterpart, Vladimir Putin to talk about finally, maybe, putting an end to Russia’s war with Ukraine. 

Notably not invited? Ukraine — or any other European leaders. 
 
Today on the show, Bloomberg editor Flavia Krause-Jackson joins host David Gura to talk about why Russia has finally agreed to talk, what’s likely to be on the table in Anchorage and how significant this summit might be.

See omnystudio.com/listener for privacy information.

What’s at Stake Ahead of Trump-Putin Meeting

After a years-long slump, Hong Kong’s IPO market is roaring back to life, thanks to a growing number of Chinese companies that are raising billions of dollars in the city. 
 
 
 
On today’s Big Take Asia Podcast, host K. Oanh Ha and Bloomberg’s Dave Sebastian explore how China is transforming the financial hub into a key funding engine for mainland firms— and the risks this poses for banks on Wall Street and beyond.

See omnystudio.com/listener for privacy information.

How China Is Bringing Hong Kong’s IPO Market Back to Life

President Trump’s so-called reciprocal tariffs have pushed the average US tariff rate to 15%, up from just over 2% last year. But who’s actually footing the bill so far?
 
On today’s Big Take podcast, Bloomberg Businessweek’s “Everybody’s Business” host Stacey Vanek Smith takes Sarah Holder through Tariff 101: How is that money being collected and where is it going?
 
Read more: It’s Only a Matter of Time Until Americans Pay for Trump’s Tariffs

See omnystudio.com/listener for privacy information.

Who’s Really Paying for Tariffs? Hint: It’s Not Foreign Companies

For years, President Donald Trump has voiced his ambitions to expand the US presence in Greenland. But making that happen is easier said than done.
 
Bloomberg’s Joe Deaux traveled to the remote island this spring, alongside a former Trump administration official who’s hoping to build a rare-earths mine there — with the federal government’s investment.
 
On today’s Big Take podcast, Joe walks host David Gura through what he saw on the ground, what Greenlanders have to say about Trump’s rhetoric and what it would really take to establish a mines-to-magnets pipeline in Greenland.
 
Read more: Greenland’s Rare-Earth Dreams Are Luring Trump Allies

See omnystudio.com/listener for privacy information.

Who Will Win the Race for Greenland’s Rare Earths?

It’s not just Levittown. The website hosting the doctored photos is the nexus of campaigns to harass women across the world. A victim in New Zealand helps to spark a global battle against the site and its elusive owner.
 
 
 
Levittown is a real-life horror story for the AI generation. In this six-part series from Bloomberg, Kaleidoscope and iHeart Podcasts, reporters Olivia Carville and Margi Murphy take listeners from quiet suburbs of New York to as far as New Zealand and into the darkest corners of the Internet. Where tech moves faster than the law, and it’s up to everyday people to hold back a rising tide of explicit deepfakes.

For official transcripts and additional information on this series, go to bloomberg.com/levittown

See omnystudio.com/listener for privacy information.

Levittown Episode 3: The Hunter

Lyt når som helst, hvor som helst

Other podcasts you might like ...